Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Accenture
Chubb
Federal Trade Commission
Mallinckrodt

Generated: August 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206494

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 206494 describes AVYCAZ, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug. Additional details are available on the AVYCAZ profile page.

The generic ingredient in AVYCAZ is avibactam sodium; ceftazidime. One supplier is listed for this compound. Additional details are available on the avibactam sodium; ceftazidime profile page.
Summary for 206494
Tradename:AVYCAZ
Applicant:Allergan Sales Llc
Ingredient:avibactam sodium; ceftazidime
Patents:8
Generic Entry Opportunity Date for 206494
Generic Entry Date for 206494*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;IV (INFUSION)

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NDA: 206494
Mechanism of Actionbeta Lactamase Inhibitors
Suppliers and Packaging for NDA: 206494
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVYCAZ avibactam sodium; ceftazidime POWDER;IV (INFUSION) 206494 NDA Allergan, Inc. 0456-2700 0456-2700-10 10 VIAL, SINGLE-USE in 1 CARTON (0456-2700-10) > 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0456-2700-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)StrengthEQ 0.5GM BASE;2GM/VIAL
Approval Date:Feb 25, 2015TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Feb 24, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:A METHOD OF TREATING BACTERIAL INFECTIONS IN COMPLICATED INTRA-ABDOMINAL INFECTION AND COMPLICATED URINARY TRACT INFECTION, INCLUDING PYELONEPHRITIS, PATIENTS COMPRISING ADMINISTERING A BACTERICIDALLY EFFECTIVE AMOUNT OF AVIBACTAM SODIUM
Patent:➤ Sign UpPatent Expiration:Feb 24, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:A METHOD OF TREATING BACTERIAL INFECTIONS IN HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNENUMONIA (HABP/VABP) PATIENTS COMPRISING ADMINISTERING A BACTERICIDALLY EFFECTIVE AMOUNT OF AVIBACTAM SODIUM
Patent:➤ Sign UpPatent Expiration:Feb 24, 2022Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson
Medtronic
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.